| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.24 | 8e-07 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-05 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.26 | 9e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |